Rhea N. Coler

Center for Infectious Disease Research — United States

Medicine · Health Sciences

56h-index13.8kcitations188works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(71), Mycobacterium research and diagnosis(43), Immune Response and Inflammation(32), Immunotherapy and Immune Responses(31), Research on Leishmaniasis Studies(30)

Publications187 total

Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine
npj Vaccines·2025· 1 citedOpen Access
T cell–macrophage interactions in tuberculosis: What we've got here is failure to communicate
Journal of Internal Medicine·2025· 2 citedOpen Access
Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection
Parasites & Vectors·2025Open Access
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units
Clinical Infectious Diseases·2025Open Access
T cell – macrophage interactions in tuberculosis as barriers to vaccine-induced immunity: What we’ve got here is failure to communicate
2025· 1 cited
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)–vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial
Science Advances·2025· 3 citedOpen Access
Intradermal Inoculation of <em>Mycobacterium avium</em> in the Mouse Ear
Journal of Visualized Experiments·2025Open Access
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum
PEDIATRICS·2025· 2 citedOpen Access
Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review
PHAGE·2025· 1 citedOpen Access
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk
Pathogens and Immunity·2025Open Access
Comparative study on the virulence of mycobacteriophages
Journal of Virology·2025Open Access
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
The Journal of Infectious Diseases·2025· 2 cited
Characterizing TLR4 agonist EmT4™ as an anti-<i>Mycobacterium tuberculosis</i> vaccine adjuvant
ImmunoHorizons·2025· 1 citedOpen Access
The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa
Vaccines·2025· 5 citedOpen Access
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients
Frontiers in Microbiology·2025· 1 citedOpen Access
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery
Virology Journal·2025· 4 citedOpen Access
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques
npj Antimicrobials and Resistance·2024· 2 citedOpen Access
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals
Frontiers in Immunology·2024· 21 citedOpen Access
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
mSphere·2024· 1 citedOpen Access
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB
UNC Libraries·2024Open Access
page 1 of 10Next →

Frequent Co-authors

Steven G. Reed(40), Sylvie Bertholet(12), Susan L. Baldwin(12), Thomas S. Vedvick(9), Antonio Campos‐Neto(8), Christopher B. Fox(7), Jill A. Ashman(7), Anna Marie Beckmann(7), Yasir A. W. Skeiky(6), Hillarie Plessner Windish(5), Malcolm S. Duthie(5), Darrick Carter(5), Lisa Bogatzki(5), Mark R. Alderson(5), Karen Cowgill(5), Stuart J. Kahn(5), Franco M. Piazza(5), Mark T. Orr(5), Elsa M. Laughlin(4), Maria Kahn(4)